Healthcare tech firm Indegene Ltd on Thursday (October 30) reported an 11.34% year-on-year increase in net profit to ₹102.1 crore for the quarter ended September 2025, compared with ₹91.7 crore in the same period last year. Revenue from operations rose 17.1% year-on-year to ₹804.2 crore from ₹686.8 crore.

The company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) grew 11.7% to ₹140.8 crore compared to ₹126.1 crore a year earlier. However, the operating margin declined to 17.5% from 18.4% in the corresponding quarter of the previous year.

Indegene has announced an investment in its wholly owned subsidiary, Indegene Ireland Ltd, to support the unit’s capital expenditure requirements aimed at expanding its business operations. The investment will be completed by

See Full Page